Latest Acquisition News

The ASX has granted key waivers allowing Southern Cross Media to proceed with its acquisition of Seven West Media without shareholder approval, smoothing the way for a major media consolidation.

Australian Finance Group Ltd (AFG) reported a robust 21% increase in net profit for FY25, driven by strategic broker network expansion and technology investments, while setting ambitious growth goals through FY29.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Forrestania Resources has completed its strategic acquisition of First Western Gold, securing control over seven exploration licenses including the promising Burracoppin Gold Project in Western Australia.

Pinnacle Minerals Ltd is fast-tracking its U.S. growth by initiating a listing on the OTCQB Market and appointing key U.S. advisers to boost investor engagement and capital access.

Ballard Mining advances its Mt Ida Gold Project with strategic land acquisitions, new mining lease applications, and a pending water licence increase, underpinning plans for a decade-long mine life.

Queensland Brine Solutions has locked in a strategic 10-hectare site to develop its Queensland Brine Management Complex, aiming to transform waste brine from the coal seam gas industry into valuable green chemicals.

Middle Island Resources has appointed Daniel Raihani as Non-Executive Chairman to steer the company through its pivotal acquisition of Serbian copper-gold assets.

Corazon Mining has completed its acquisition of the Two Pools Gold Project, alongside a $2 million capital raise and a significant share consolidation, positioning itself for accelerated exploration in Western Australia’s prolific Gascoyne region.

AuKing Mining advances its strategic acquisition of Orion Resources and the Cloncurry Gold Project while securing a $5 million loan facility and progressing exploration across multiple continents.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

IMDEX Limited reported a resilient FY25 with steady margins, reduced net debt, and strategic acquisitions positioning it for growth. The company’s FY26 outlook is optimistic, supported by improving global exploration activity and technology adoption.